Last reviewed · How we verify

NCT03458143

Respiratory Depression During an Analgosedation Combining Remifentanil and Ketamine in TCI for Oocyte Retrieval

Status unknown Last updated 13 March 2018
What this trial tests

trial testing Ketamine 150 ng/ml in Oocyte Retrieval in 20 participants. Status unknown.

Timeline
12 February 2018
Primary endpoint
31 March 2018
31 March 2018

Quick facts

Lead sponsorErasme University Hospital
StatusStatus unknown
Study typeOBSERVATIONAL
Enrollment20
Start date12 February 2018
Primary completion31 March 2018
Estimated completion31 March 2018
Sites1 location across Belgium

Drugs / interventions tested

Conditions studied

Sponsor

Erasme University Hospital

Who can join

18 and older, female only, with Oocyte Retrieval or Sedation, Conscious. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study evaluates the effect of the addition of ketamine to a conscious sedation protocol including remifentanil during oocyte retrieval. The investigators will have 2 groups with different target effect site concentrations, namely 150 ng/ml and 200 ng/ml.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Oocyte Retrieval

Currently open trials in the same condition.

Other Erasme University Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03458143.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing